Literature DB >> 24093934

Laparoscopic central pancreatectomy with pancreaticojejunostomy: preliminary experience with 8 cases.

Renchao Zhang1, Xiaowu Xu, Jiafei Yan, Di Wu, Harsha Ajoodhea, Yiping Mou.   

Abstract

BACKGROUND: Central pancreatectomy has been accepted as an alternative procedure for treating benign or low-grade malignant tumors in the pancreatic neck or proximal body of the pancreas, which preserves pancreatic parenchyma and function. In this study, we present our experience of laparoscopic central pancreatectomy with pancreaticojejunostomy. PATIENTS AND METHODS: From April 2011 to February 2013, 8 patients underwent laparoscopic central pancreatectomy with a Roux-en-Y modified "dunking" or duct-to-mucosa pancreaticojejunostomy for benign or low-grade malignant tumors in the pancreatic neck or proximal body of the pancreas at the Department of General Surgery, Sir Run Run Shaw Hospital, Hangzhou, China. Surgical procedure, postoperative course, and follow-up data were collected.
RESULTS: Laparoscopic central pancreatectomy was performed successfully in all the patients. The pancreaticojejunostomy was executed with a modified "dunking" pancreaticojejunostomy (n=7) or duct-to-mucosa pancreaticojejunostomy (n=1). The mean operative time was 286±27 minutes (range, 250-330 minutes), with a mean blood loss of 57±21 mL (range, 30-100 mL). Mortality was 0%, and perioperative morbidity was 37.5% (pancreatic fistula [grade A], bleeding of a splenic vein branch, and retroperitoneal infection). The median postoperative hospital stay was 10 days (range, 6-38 days). At a median follow-up of 7.5 months (range, 2-24 months), all patients were alive without any exocrine or endocrine insufficiency or recurrence.
CONCLUSIONS: Laparoscopic central pancreatectomy is feasible and safe. The modified "dunking" pancreaticojejunostomy can be performed safely in this approach.

Entities:  

Mesh:

Year:  2013        PMID: 24093934     DOI: 10.1089/lap.2013.0269

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  5 in total

1.  Comparison of clinical outcomes and quality of life between laparoscopic and open central pancreatectomy with pancreaticojejunostomy.

Authors:  Ren-Chao Zhang; Bin Zhang; Yi-Ping Mou; Xiao-Wu Xu; Yu-Cheng Zhou; Chao-Jie Huang; Jia-Yu Zhou; Wei-Wei Jin; Chao Lu
Journal:  Surg Endosc       Date:  2017-04-19       Impact factor: 4.584

2.  Robot-assisted laparoscopic versus open middle pancreatectomy: short-term results of a randomized controlled trial.

Authors:  Shi Chen; Qian Zhan; Jia-Bin Jin; Zhi-Chong Wu; Yuan Shi; Dong-Feng Cheng; Hao Chen; Xia-Xing Deng; Bai-Yong Shen; Cheng-Hong Peng; Hong-Wei Li
Journal:  Surg Endosc       Date:  2016-07-11       Impact factor: 4.584

3.  Binding pancreaticogastrostomy in laparoscopic central pancreatectomy: a novel technique in laparoscopic pancreatic surgery.

Authors:  Defei Hong; Yingbin Liu; Shuyou Peng; Xiaodong Sun; Zhifei Wang; Jian Cheng; Guoliang Shen; Yuanbiao Zhang; Dongsheng Huang
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

4.  Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference.

Authors:  Bjørn Edwin; Mushegh A Sahakyan; Mohammad Abu Hilal; Marc G Besselink; Marco Braga; Jean-Michel Fabre; Laureano Fernández-Cruz; Brice Gayet; Song Cheol Kim; Igor E Khatkov
Journal:  Surg Endosc       Date:  2017-02-15       Impact factor: 4.584

5.  A rare case of mixed mucinous cystadenoma with serous cystadenoma of the pancreas treated by laparoscopic central pancreatectomy.

Authors:  Ren-chao Zhang; Xiao-wu Xu; Yu-cheng Zhou; Di Wu; Harsha Ajoodhea; Ke Chen; Yi-ping Mou
Journal:  World J Surg Oncol       Date:  2014-10-16       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.